Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(10)
DRUG(6)
BIOLOGICAL(3)
DEVICE(2)
Apheresis
1 trial
phase_2
national-cancer-institute-nci
Hepatitis B Vaccine
1 trial
phase_2
national-cancer-institute-nci
Polio Vaccine
1 trial
phase_2
national-cancer-institute-nci
Hepatitis A Vaccine
1 trial
phase_2
national-cancer-institute-nci
Single fraction radiation
1 trial
phase_2
national-cancer-institute-nci
Allogeneic stem cell transplant
1 trial
national-cancer-institute-nci
Singulair (Montelukast Sodium)
1 trial
phase_2
national-cancer-institute-nci
Access to unlicensed cord blood units
1 trial
phase_2
national-cancer-institute-nci

+14 more interventions

22 unique interventions5 categories

Analytics

Trial Phases

Phase 12
Phase 26

Trial Status

Completed3
Terminated6
Other1

Role Distribution

Principal Investigator10
PI Rate100%

Activity Timeline

Clinical Trials (10)

NCT02322190Phase 2Terminated
Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD
Chronic Graft vs. Host DiseaseGraft vs Host DiseaseGraft-Versus-Host Disease
PrincipalinvestigatorStart date: 2014-12-20
NCT01326728Terminated
Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaChronic Myelogenous Leukemia+2 more
PrincipalinvestigatorStart date: 2011-03-30
NCT00984165Phase 2Terminated
Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation
Chronic Lymphocytic LeukemiasHodgkin's LymphomaMultiple Myeloma With Plasmacytoma+1 more
PrincipalinvestigatorStart date: 2010-01-19
NCT00656058Phase 2Completed
Montelukast to Treat Bronchiolitis Obliterans
Bronchiolitis ObliteransChronic Graft Versus Host DiseaseLeukotriene+2 more
PrincipalinvestigatorStart date: 2008-06-17
NCT00001507Phase 1Completed
Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer
Breast NeoplasmNeoplasm Metastasis
Principalinvestigator
NCT00031538Terminated
Genetic Analysis of Brain Tumors
Anaplastic AstrocytomaAstrocytomaGlioblastoma Multiforme+2 more
Principalinvestigator
NCT00427726Completed
Follow-up of Breast Cancer and Multiple Myeloma Patients Previously Enrolled in NIH Gene Therapy Studies
Gene Transfer
Principalinvestigator
NCT01339000Phase 2Terminated
Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy
Bladder CancerBreast CancerColon Cancer
Principalinvestigator
NCT01479582Phase 2Withdrawn
Providing Access to Cord Blood Units for Transplants
Acute LeukemiasChronic Myelogous Leukemia/Other LeukemiaMDS/MPS+2 more
Principalinvestigator
NCT01658904Phase 1/2Terminated
Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma
Leukemia, Plasma CellMultiple Myeloma
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft vs Host Disease+5 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteChronic Graft-Versus-Host DiseaseGraft vs Host Disease+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Breast CancerUrinary Bladder CancerCancer of Colon+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinAnaplastic AstrocytomaCancer of Colon+1 more
Similarity Score4%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaChronic Graft-Versus-Host Disease+1 more
Similarity Score4%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinBreast CancerMultiple Myeloma+1 more
Similarity Score4%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Norman Wolmark, MD

NSABP Foundation Inc

Related
54 trials

Shared therapeutic areas:

Breast CancerBreast NeoplasmsCancer of Colon

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Breast CancerNeoplasm Metastasis
Similarity Score2%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-Hodgkin

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (10)

Showing 10 of 10 trials

NCT02322190Phase 2PrincipalInvestigator

Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD

Chronic Graft vs. Host DiseaseGraft vs Host DiseaseGraft-Versus-Host Disease
Terminated
NCT01326728PrincipalInvestigator

Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation

Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaChronic Myelogenous Leukemia+2 more
Terminated
NCT00984165Phase 2PrincipalInvestigator

Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation

Chronic Lymphocytic LeukemiasHodgkin's LymphomaMultiple Myeloma With Plasmacytoma+1 more
Terminated
NCT00656058Phase 2PrincipalInvestigator

Montelukast to Treat Bronchiolitis Obliterans

Bronchiolitis ObliteransChronic Graft Versus Host DiseaseLeukotriene+2 more
Completed
NCT00001507Phase 1PrincipalInvestigator

Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer

Breast NeoplasmNeoplasm Metastasis
Completed
NCT00031538PrincipalInvestigator

Genetic Analysis of Brain Tumors

Anaplastic AstrocytomaAstrocytomaGlioblastoma Multiforme+2 more
Terminated
NCT00427726PrincipalInvestigator

Follow-up of Breast Cancer and Multiple Myeloma Patients Previously Enrolled in NIH Gene Therapy Studies

Gene Transfer
Completed
NCT01339000Phase 2PrincipalInvestigator

Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy

Bladder CancerBreast CancerColon Cancer
Terminated
NCT01479582Phase 2PrincipalInvestigator

Providing Access to Cord Blood Units for Transplants

Acute LeukemiasChronic Myelogous Leukemia/Other LeukemiaMDS/MPS+2 more
Withdrawn
NCT01658904Phase 1/2PrincipalInvestigator

Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma

Leukemia, Plasma CellMultiple Myeloma
Terminated

All 10 trials loaded